Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Panel of broadly neutralizing SARS-CoV-2 nanobodies for immune assay application

In this study, a team of researchers from Japanese institutions provide a panel of broadly neutralizing nanobodies that detect four VOCs.

28 Oct 2021

Two-dose SARS-CoV-2 vaccine effectiveness against infection and hospitalization in Canada

Authors from varying Canadian institutes report on two-dose vaccine effectiveness against infection and hospitalization.

28 Oct 2021

Japanese study on SARS-CoV-2 breakthrough infections

Researchers evaluated SARS-CoV-2 incidence in Japan regarding the timing of the vaccination program and surge in COVID-19 cases among the staff of a large referral hospital in Tokyo. This study is posted to the medRxiv* preprint server.

28 Oct 2021

N antibodies following SARS-CoV-2 Alpha and Delta infections by vaccination status

A new study, published on the medRxiv* preprint server, has focused on the use of anti-nucleocapsid (N) antibody positivity as a marker of SARS-CoV-2 infection. In the present study, these antibody markers were evaluated using serological surveillance studies post-vaccination amidst circulation of variants of concern.

28 Oct 2021

Routine surveillance helps detect asymptomatic SARS-CoV-2 vaccine breakthrough infections

In a study published in Annals of Internal Medicine, researchers from Italy systematically monitored 2,397 HCWs who were fully vaccinated with BNT162 at the ASST Settelaghi hospitals in Lombardy, Italy during February 2021. HCWs who worked in 8 wards deemed at “high risk” for infection from attending patients had to undergo mandatory nasopharyngeal swab testing with SARS-CoV-2 polymerase chain reaction every two weeks. HCWs working in 8 “moderate-risk” wards were tested every four weeks.

28 Oct 2021

COVID vaccines deployed in US highly effective at reducing hospitalizations and deaths

Researchers in the United States have conducted a large-scale study showing that the two-dose regimen vaccines developed by Pfizer-BioNTech and Moderna to protect against coronavirus disease 2019 (COVID-19) appear to be highly effective and durable in reducing the risk of hospitalizations and deaths following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

28 Oct 2021

SARS-CoV-2 vaccination lowers risk of several outcomes after breakthrough infection

Researchers at the University of Oxford have conducted a study showing that vaccination against coronavirus disease 2019 (COVID-19) is associated with a lower risk of several sequelae among those who experience breakthrough infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

28 Oct 2021

Chlorophyll catabolite pheophorbide A shows potential against SARS-CoV-2

A new study identifies a potent SARS-CoV-2 antiviral, Pheophorbide a (PheoA), which is a compound derived from the plant Marchantia polymorpha L.

27 Oct 2021

Undetected SARS-CoV-2 community transmission drove the first wave of COVID-19

Researchers find that the exponential spread of SARS-CoV-2 went largely unrecognized early on in 2020.

27 Oct 2021

COVID-19 and subacute neuropsychiatric symptoms in adolescents

A new paper discusses neurologic symptoms in children with COVID-19.

27 Oct 2021

The difference in the dynamics of SARS-COV-2 variants

A new study provides a detailed description of the varying interactions between SARS-CoV-2 and the host cell ACE-2 receptor.

27 Oct 2021

Taking lessons in molecular therapeutics from earthworms to combat COVID

Scientists were interested in further investigating the defense mechanism of earthworms in an effort to discover therapeutic solutions against SARS-CoV-2.

27 Oct 2021

How do COVID-19 vaccination mandates affect vaccine uptake?

A new study aimed to evaluate and quantify the effect of proof of vaccination mandates on first-dose vaccine uptake.

27 Oct 2021

Study shows efficacy of a heterologous vaccine regimen to induce mucosal protection against COVID-19

Researchers emphasize that an effective vaccine should induce mucosal immunity and prevent the nasal entry of SARS-CoV-2.

27 Oct 2021

A study on the SARS-CoV-2 B.1.620 lineage

In a recently published Nature Communications study, the authors describe the B.1.620 lineage discovered in Lithuania.

27 Oct 2021

How do asymptomatic COVID-19 screenings affect a highly vaccinated university population?

In a recent study, a team of researchers from a variety of Canadian institutes reviewed the previous modeling of COVID-19 transmission in a university setting.

27 Oct 2021

Studies test intravenous immunoglobulin for treatment of Kawasaki disease and MIS-C

Kawasaki disease (KD) is rare, with fewer than 6,000 diagnosed cases per year in the United States. It is most common in infants and young children and causes inflammation in the walls of some blood vessels in the body.

27 Oct 2021

Immunogenicity and efficacy of heterologous ChadOx1/BNT162b2 vaccination amongst healthcare workers

The heterologous ChAd/BNT combination confers better protection against SARS-CoV-2 infection than the homologous BNT/BNT combination in a real-world observational study of healthcare workers.

27 Oct 2021

COVID-19 vaccine-elicited immune responses in myeloma patients

Researchers collaborated to address these evidence gaps by initiating a web-based prospective study of adults diagnosed with multiple myeloma to determine the immune response to the first and second dose of the COVID-19 vaccine.

27 Oct 2021

Do pre-existing mental disorders and their co-occurrence affect COVID-19 clinical outcomes?

Researchers conducted a study to assess how pre-existing mental disorders are associated with a SARS-CoV-2 infection and how different clusters of mental disorders affect COVID-19 clinical outcomes.

27 Oct 2021

Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Panel of broadly neutralizing SARS-CoV-2 nanobodies for immune assay application

Two-dose SARS-CoV-2 vaccine effectiveness against infection and hospitalization in Canada

Japanese study on SARS-CoV-2 breakthrough infections

N antibodies following SARS-CoV-2 Alpha and Delta infections by vaccination status

Routine surveillance helps detect asymptomatic SARS-CoV-2 vaccine breakthrough infections

COVID vaccines deployed in US highly effective at reducing hospitalizations and deaths

SARS-CoV-2 vaccination lowers risk of several outcomes after breakthrough infection

Chlorophyll catabolite pheophorbide A shows potential against SARS-CoV-2

Undetected SARS-CoV-2 community transmission drove the first wave of COVID-19

COVID-19 and subacute neuropsychiatric symptoms in adolescents

The difference in the dynamics of SARS-COV-2 variants

Taking lessons in molecular therapeutics from earthworms to combat COVID

How do COVID-19 vaccination mandates affect vaccine uptake?

Study shows efficacy of a heterologous vaccine regimen to induce mucosal protection against COVID-19

A study on the SARS-CoV-2 B.1.620 lineage

How do asymptomatic COVID-19 screenings affect a highly vaccinated university population?

Studies test intravenous immunoglobulin for treatment of Kawasaki disease and MIS-C

Immunogenicity and efficacy of heterologous ChadOx1/BNT162b2 vaccination amongst healthcare workers

COVID-19 vaccine-elicited immune responses in myeloma patients

Do pre-existing mental disorders and their co-occurrence affect COVID-19 clinical outcomes?

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in